diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...
In experiments, researchers showed that the disease-spreading insects couldn’t resist the sweet smell of a fungus that infected and killed them.
"Today's decision is a landmark victory for the public's right to know what they eat and feed their families," said George ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...
A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
The team found that neurons from individuals with postmortem CTE diagnoses had specific abnormal patterns of somatic genome ...
A newly discovered protein from Earth's toughest animal is inspiring breakthrough therapies for cancer and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback